Updated Interim Results of AAVance, a Gene Therapy Study in Children with Mucopolysaccharidosis IIIA

Time: 10:45 am
day: Day Two

Details:

  • Safety update
  • Biomarker data
  • Evolution of developmental age

Speakers:

Ralph Laufer
Ralph Laufer

Read more